C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes

More topics under "C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes" (300,877)
C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
C12Q 3 - Condition-responsive control processes (646)

Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829)
12/2004
12/15/2004	EP1485499A1 Novel primers for screening schizophrenia and a method thereof
12/15/2004	EP0576558B1 Nucleic acid typing by polymerase extension of oligonucleotides using terminator mixtures
12/15/2004	CN1555418A Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivatives
12/09/2004	WO2004061123A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
12/09/2004	WO2004050848A3 Methods for antigen masking of red blood cells resulting in reduced hemolysis
12/09/2004	WO2004046369A3 Nucleic acid sequence detection
12/09/2004	WO2004042074A3 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein
12/09/2004	WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
12/09/2004	US20040248808 Methods for preventing mitochondrial permeability transition
12/09/2004	US20040248773 Methods for the identification of inhibitors of pyrroline-5-carboxylate reductase as antibiotics
12/09/2004	US20040248095 Contacting with primer, hybridizing, separating extension products from single stranded molecules, and replicating; kits
12/08/2004	EP1484415A2 Method of alleviating pest infestation in plants
12/08/2004	EP1330553A4 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus
12/02/2004	WO2004104214A2 Methods and devices for multiplexing amplification reactions
12/02/2004	WO2004104213A2 Nucleic acids and polypeptides of c1 bacteriophage and uses thereof
12/02/2004	WO2004104212A2 Molecular signature and assay for fluoroquinoline resistance in bacillus anthracis
12/02/2004	WO2004104211A2 Method for detecting toxic and non-toxic cyanobacteria
12/02/2004	WO2004044218A3 Methods and materials for examining pathways associated with glioblastoma progression
12/02/2004	US20040242461 Modulators of telomere stability
12/01/2004	EP1481088A2 Polynomial amplification of nucleic acids
11/2004
11/25/2004	WO2004102195A1 Method for identifying tff2 regulating agents and agents identified using said method
11/25/2004	WO2004101808A2 Genomic and proteomic approaches for the development of cell culture medium
11/25/2004	WO2004101807A2 High troughput monitoring chamber for testing drug effects on repolarization and conduction
11/25/2004	WO2004050896A9 A method and therapeutic platelets
11/25/2004	WO2003078652A3 Modification of selectivity for sensing for nanostructure device arrays
11/25/2004	WO2003072805A3 Recombinase polymerase amplification
11/25/2004	US20040235075 Rapid immunoassay of anthrax protective antigen in vaccine cultures and bodily fluids by fluorescence polarization
11/25/2004	US20040234960 Evaluating methylation status of nucleotide sequences; treat sequences and convert cytosine to uracil, amplify segment comprising 5-methyl cytosine, hybridize with peptide nucleic acid and oligomers, evaluate methylation and quantify amplification products
11/18/2004	WO2004099436A2 Structural and cytoskeleton-associated proteins
11/18/2004	WO2004099435A2 Apparatus for the automated synthesis of polynucleotides
11/18/2004	WO2004099434A2 Homogeneous multiplex screening assays and kits
11/18/2004	WO2004099432A2 Identification of biomarkers for detecting pancreatic cancer
11/18/2004	WO2004065616A3 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
11/18/2004	WO2004050899A3 Method for in vitro selection of 2’-substituted nucleic acids
11/18/2004	WO2004048591A3 Methods for cohort selection and longevity studies
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040229300 Zinc-based screening test and kit for early diagnosis of prostate cancer
11/18/2004	US20040229242 Methods of capturing, detecting and quantifying RNA:DNA hybrids and a modified RNase H useful therein
11/18/2004	CA2524660A1 Apparatus for the automated synthesis of polynucleotides
11/18/2004	CA2524080A1 Homogeneous multiplex screening assays and kits
11/17/2004	EP1476578A2 Mismatch repair detection
11/11/2004	WO2004097032A2 Method for nucleic acid sequencing
11/11/2004	WO2004097031A2 Methods for detecting methylated promoters based on differential dna methylation
11/11/2004	WO2004097030A2 Prognostic breast cancer biomarkers
11/11/2004	WO2004097029A2 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
11/11/2004	WO2004097028A2 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance and deuterium
11/11/2004	WO2004097027A2 Screening of biocatalysts in plants
11/11/2004	WO2004044227A3 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
11/11/2004	WO2004038037A3 Controlled alignment of nano-barcodes encoding specific information for scanning probe microscopy (spm) reading
11/11/2004	WO2004024941A3 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
11/11/2004	US20040224336 RecA-assisted specific oligonucleotide extension method for detecting mutations, SNPs and specific sequences
11/11/2004	US20040223885 for maintaining closed continuous anhydrous system for automated polynucleotide synthesis, having moisture-resistant reagent containers, dry box capable of forming seal over synthesis platform, moisture-resistant tubing connecting reagent containers to dry box, reagent gas feed to pressurize containers
11/11/2004	CA2523919A1 Method for nucleic acid sequencing
11/11/2004	CA2523016A1 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
11/10/2004	EP1474768A2 Methods for searching polynucleotide probe targets in databases
11/10/2004	EP1474530A2 Probe correction for gene expression level detection
11/10/2004	EP1474434A2 The eaat2 promoter and uses thereof
11/04/2004	WO2004094988A2 Tolerance to graft prior to thymic regeneration
11/04/2004	WO2004094655A2 Modulation of telomere-initiated cell signaling
11/04/2004	WO2004094654A2 Transfection kinetics and structural promoters
11/04/2004	WO2004094653A2 Differential tag length analysis of cell proliferation
11/04/2004	WO2004094652A2 Zinc-based screening test and kit for early diagnosis of prostate cancer
11/04/2004	WO2004094651A2 Novel human polypeptides encoded by polynucleotides
11/04/2004	WO2004094649A2 Tolerance to graft following thymic reactivation
11/04/2004	WO2004094648A2 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	WO2004094647A2 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	WO2004080271A3 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
11/04/2004	WO2004067762A3 Crystallized structure of type iv collagen nc1 domain hexamer
11/04/2004	WO2004047514A3 Methods for identifying risk of breast cancer and treatments thereof
11/04/2004	WO2003102209A3 Alternatively spliced isoforms of human hmg co-a reductase
11/04/2004	US20040219605 Fluid planar lipid layer-based membrane-anchored ligand system with defined ligand valency and methods of use thereof
11/04/2004	US20040219513 Method of screening a metabolite of a parent candidate compound for susceptibility to biliary excretion
11/04/2004	CA2528503A1 Tolerance to graft prior to thymic regeneration
11/04/2004	CA2526915A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2522700A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2519897A1 Modulation of telomere-initiated cell signaling
11/02/2004	US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
10/2004
10/28/2004	WO2004092399A2 Real-time polmerase chain reaction-based genotyping assay for single nucleotide polymorphism
10/28/2004	WO2004092398A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
10/28/2004	WO2004092397A2 Tmprss2 regulatory sequences and uses thereof
10/28/2004	WO2004092396A2 Flap endonuclease 1 (fen1) regulatory sequences and uses thereof
10/28/2004	WO2004092395A2 Modulators of telomere stability
10/28/2004	WO2004092394A2 Fluid planar lipid layer-based membrane-anchored ligand system with specific binding pair members and methods of use thereof
10/28/2004	US20040214226 Method of screening candidate compounds for susceptibility to biliary excretion by endogenous transport systems
10/28/2004	US20040214199 comprising protected hydrazino, oxyamino and carbonyl-based groups biochemical immobilization; solid phase synthesis
10/28/2004	US20040214196 Using ligation and amplification to detect preferential sequences nucleic acids; diagnosing infection and cell proliferative disorders
10/28/2004	US20040213861 Process and composition for inhibiting growth of microorganisms
10/28/2004	CA2521754A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
10/21/2004	WO2004090154A2 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis
10/21/2004	WO2004090153A2 Polymerase inhibitor and method of using same
10/21/2004	WO2004050029A3 Novel activated polyethylene glycol compounds
10/21/2004	WO2004044222A3 Polymeric prodrugs of vancomycin
10/21/2004	WO2003104478A3 Detection of rna structural elements
10/21/2004	WO2003102219A3 Improved pseudotyped retroviruses
10/21/2004	US20040209353 Apparatus which utilizes ribozymes, DNAzymes or catalytic antibodies to detect pathogens in blood products
10/21/2004	US20040209309 Compositions and methods for the specific detection of mammalian muscle proteins
10/21/2004	US20040209283 Using oligonucleotide templates and fluorescent dyes to screen for hepatitis c viral polymerase activity; viricides
10/21/2004	CA2521130A1 Acyl-phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis
10/21/2004	CA2521127A1 Polymerase inhibitor and method of using same
10/20/2004	CN1539022A Viral drug susceptibility testing

1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 29